Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep;239(9):1225-39.
doi: 10.1177/1535370214529397. Epub 2014 Jun 20.

Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposure

Jong Hwan Sung  1 , Balaji Srinivasan  2 , Mandy Brigitte Esch  3 , William T McLamb  2 , Catia Bernabini  2 , Michael L Shuler  4 , James J Hickman  5
Affiliations
Review

Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposure

Jong Hwan Sung et al. Exp Biol Med (Maywood). 2014 Sep.

Abstract

The continued development of in vitro systems that accurately emulate human response to drugs or chemical agents will impact drug development, our understanding of chemical toxicity, and enhance our ability to respond to threats from chemical or biological agents. A promising technology is to build microscale replicas of humans that capture essential elements of physiology, pharmacology, and/or toxicology (microphysiological systems). Here, we review progress on systems for microscale models of mammalian systems that include two or more integrated cellular components. These systems are described as a "body-on-a-chip", and utilize the concept of physiologically-based pharmacokinetic (PBPK) modeling in the design. These microscale systems can also be used as model systems to predict whole-body responses to drugs as well as study the mechanism of action of drugs using PBPK analysis. In this review, we provide examples of various approaches to construct such systems with a focus on their physiological usefulness and various approaches to measure responses (e.g. chemical, electrical, or mechanical force and cellular viability and morphology). While the goal is to predict human response, other mammalian cell types can be utilized with the same principle to predict animal response. These systems will be evaluated on their potential to be physiologically accurate, to provide effective and efficient platform for analytics with accessibility to a wide range of users, for ease of incorporation of analytics, functional for weeks to months, and the ability to replicate previously observed human responses.

Keywords: Microphysiological system; PBPK models; chemical analysis; electrical analysis; mechanical analysis; microfabrication.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) one-compartment model (B) two-compartment model (C) PBPK model (D) diffusion-limited model.
Figure 2
Figure 2
Design of body-on-a-chip devices based on PBPK modeling principles.
See this image and copyright information in PMC

References

    1. Lau YY, Chen YH, Liu TT, Li C, Cui X, White RE, Cheng KC. Evaluation of a novel in vitro Caco-hepatocyte hybrid system for predicting in vivo oral bioavailability. Drug Metab Dispos. 2004;32:937–942. - PubMed
    1. Li AP, Bode C, Sakai Y. A novel in vitro system, the integrated discrete multiple organ cell culture (IdMOC) system, for the evaluation of human drug toxicity: comparative cytotoxicity of tamoxifen towards normal human cells from five major organs and MCF-7 adenocarcinoma breast cancer cells. Chem Biol Interact. 2004;150:129–136. - PubMed
    1. Lotito SB, Frei B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med. 2006;41:1727–1746. - PubMed
    1. Sung JH, Esch MB, Prot JM, Long CJ, Smith A, Hickman JJ, Shuler ML. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip. 2013;13:1201–1212. - PMC - PubMed
    1. Sung JH, Esch MB, Shuler ML. Integration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling. Expert Opin Drug Metab Toxicol. 2010;6:1063–1081. - PubMed

Publication types

MeSH terms